Review3 Biotech2022

Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.

José Ednésio da Cruz Freire et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.